Researchers performed anterior lumbar interbody fusion in 11 Yorkshire pigs with either medical grade poly-20 percent tricalcium phosphate, autologous bone grafts, mPCL/TCP and bone marrow-derived multipotent stromal cells or a combination of mPCL/TCP and 0.6 mg of rhBMP-2.
The group with BMSCs lagged behind autograft bone and rhBMP-2, although there was evidence of bone growth that could constitute additional research. There was no implant rejection, chronic inflammation or other complications.
The authors suggested mPCL/TCP scaffolds loaded with rhBMP-2 or BMSCs could be a good alternative to conventional cages and autograft bone.
Related Articles on BMP:
Study: BMP Use Increases Complication Risk Only in Anterior Cervical Fusion
Study: 85% of BMP Procedures Between 2002 and 2007 Used for Off-Label Applications
NASS: BMP Use in Spinal Fusions May Cause Male Infertility
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
